DE68901619D1 - Osmotisches system zur verabreichung von verduennten loesungen. - Google Patents

Osmotisches system zur verabreichung von verduennten loesungen.

Info

Publication number
DE68901619D1
DE68901619D1 DE8989300582T DE68901619T DE68901619D1 DE 68901619 D1 DE68901619 D1 DE 68901619D1 DE 8989300582 T DE8989300582 T DE 8989300582T DE 68901619 T DE68901619 T DE 68901619T DE 68901619 D1 DE68901619 D1 DE 68901619D1
Authority
DE
Germany
Prior art keywords
agent
delivered
bodies
administrating
thinned
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8989300582T
Other languages
German (de)
English (en)
Inventor
Kelly L Smith
Wendy P Robinson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bend Research Inc
Original Assignee
Bend Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bend Research Inc filed Critical Bend Research Inc
Application granted granted Critical
Publication of DE68901619D1 publication Critical patent/DE68901619D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
DE8989300582T 1988-01-22 1989-01-23 Osmotisches system zur verabreichung von verduennten loesungen. Expired - Fee Related DE68901619D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14718288A 1988-01-22 1988-01-22

Publications (1)

Publication Number Publication Date
DE68901619D1 true DE68901619D1 (de) 1992-07-02

Family

ID=22520578

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8989300582T Expired - Fee Related DE68901619D1 (de) 1988-01-22 1989-01-23 Osmotisches system zur verabreichung von verduennten loesungen.

Country Status (7)

Country Link
EP (1) EP0325492B1 (cg-RX-API-DMAC7.html)
JP (1) JPH025978A (cg-RX-API-DMAC7.html)
AT (1) ATE76574T1 (cg-RX-API-DMAC7.html)
CA (1) CA1330886C (cg-RX-API-DMAC7.html)
DE (1) DE68901619D1 (cg-RX-API-DMAC7.html)
ES (1) ES2033085T3 (cg-RX-API-DMAC7.html)
GR (1) GR3005289T3 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5045082A (en) * 1990-01-10 1991-09-03 Alza Corporation Long-term delivery device including loading dose
US6706283B1 (en) 1999-02-10 2004-03-16 Pfizer Inc Controlled release by extrusion of solid amorphous dispersions of drugs
WO2001067094A2 (en) * 2000-03-06 2001-09-13 Groundwater Chemtest Aps Device and method for bringing a compound into contact with an environment
MXPA04002891A (es) 2001-09-28 2005-06-20 Johnson & Johnson Composicion farmaceutica a base de pasta de azucar.
US7807197B2 (en) 2002-09-28 2010-10-05 Mcneil-Ppc, Inc. Composite dosage forms having an inlaid portion
CA2499979C (en) * 2002-09-28 2012-09-11 Mcneil-Ppc, Inc. Immediate release dosage form comprising shell having openings therein
US8067029B2 (en) 2004-01-13 2011-11-29 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
US7879354B2 (en) 2004-01-13 2011-02-01 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
AU2011256259A1 (en) 2010-05-17 2012-11-08 Novaer Holdings, Inc. Drug delivery devices for delivery of ocular therapeutic agents
JP2012025708A (ja) * 2010-07-27 2012-02-09 Sepa Sigma Inc 膜透過機構を異にする複数の徐放機構を利用した徐放化局所投与剤
EP3706848A1 (en) * 2017-11-09 2020-09-16 TARIS Biomedical LLC Drug delivery devices and methods for use with a urinary catheter

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4278087A (en) * 1980-04-28 1981-07-14 Alza Corporation Device with integrated operations for controlling release of agent

Also Published As

Publication number Publication date
ES2033085T3 (es) 1993-03-01
EP0325492A1 (en) 1989-07-26
ATE76574T1 (de) 1992-06-15
JPH025978A (ja) 1990-01-10
EP0325492B1 (en) 1992-05-27
CA1330886C (en) 1994-07-26
GR3005289T3 (cg-RX-API-DMAC7.html) 1993-05-24

Similar Documents

Publication Publication Date Title
IL91398A0 (en) Use of asymmetric membranes in delivery devices
ATE110578T1 (de) Von hydrogel angetriebene verabreichungsvorrichtung.
DE68901619D1 (de) Osmotisches system zur verabreichung von verduennten loesungen.
DE69220808D1 (de) Vorrichtung zur verabreichung von heilmitteln
DE3681570D1 (de) Medizinische einrichtung zur pulsatilen transdermalen verabreichung von biologisch aktiven wirkstoffen.
FI943066A0 (fi) Polymeerikalvojen uusi käyttö kvaternäärisiä ammoniumyhdisteitä säilöntäaineena sisältävien farmaseuttisten liuosten annostelussa ja vastaava annosjakelija
KR900701274A (ko) 남용 가능성을 감소시킨 용량 제형
GR3004404T3 (cg-RX-API-DMAC7.html)
DE3766308D1 (de) Kombination von carbidopa/levodopa mit verzoegerter wirkstoffabgabe.
CA2098195A1 (en) Subsaturated transdermal drug delivery device exhibiting enhanced drug flux
DE3866817D1 (de) Knochenzement zur kontrollierten abgabe von wirkstoffen.
ATE25587T1 (de) Vorrichtung zur verabreichung von arzneimitteln.
ATE63059T1 (de) Vorrichtung mit zwei schichten zur freisetzung von arzneimitteln.
ZA891949B (en) Reservoir for controlled active substance delivery,apparatus containing the same,as well as method for its manufacture and use of the apparatus
ES2025085B3 (es) Una estructura laminar para la administracion de un producto quimico a una velocidad de liberacion controlada.
ATE31002T1 (de) Verfahren zur herstellung von fluessigen pflanzenschutzmittelkombinationen.
ATE238063T1 (de) Wässrige zusammensetzung mit verzögerter freisetzung, enthaltend rinderwachstumshormon- freisetzungsfaktor
ATE126437T1 (de) Verwendung von depogen zur behandlung von eingeschränktem blutkreislauf.
DE3873027D1 (de) Vorrichtung zur langsamen abgabe eines fluessigen wirkstoffs.
ATE87482T1 (de) Pharmazeutische praeparate zur behandlung von zereberalen psycho-organischen syndromen.
LUEDEMANN et al. TOXICITY AND TEMPORAL CHANGES IN CONCENTRATION OF THE INSECTICIDE PARATHION IN WATER,(IN GERMAN)
Saxena et al. Effect of Safe Application Rate(SAR) Concentrations of Some Biocides on the Gonads of the Water Murrel, Channa punctatus(Bl.)-A Biochemical Study
KR880010660A (ko) 수경재배용 비료의 배합방법
DK594889A (da) Reservoir til styret medikamentafgivelse, indretning indeholdende saadant reservoir samt fremgangsmaade til fremstilling og anvendelse af indretningen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee